Search for: "Novartis Ag"
Results 281 - 300
of 440
Sorted by Relevance
|
Sort by Date
14 Jul 2010, 6:47 pm
Abbott Laboratories Ltd v Medinol Ltd (PatLit) US: Analysis shows patent use codes have doubled since August 2003 (FDA Law Blog) US: House slips pay-for-delay provision into Appropriations Bill (Patent Docs) US: Novartis challenges USPTO’s interim procedure for requesting PTA recalculations (Patent Docs) US: Seven actions related to Enzo’s patents for detecting DNA stayed pending Supreme Court review (Patent Docs) US: Review and correction of the patent term adjustment… [read post]
18 Nov 2009, 4:57 am
(Patent Docs) Dovonex (Calcipotriol) – UK: EWHC dismisses Sandoz appeal against Floyd J’s finding that Leo Pharma’s patent was valid (PatLit) Humira (Adalimumab): US: District Court E D Texas upholds record $1.7 billion infringement judgment: Centocor v Abbott (Patent Docs) (EDTexweblog.com) Lexapro (Citalopram) – US: Infosint seeks increased damages award in Citalopram suit (Patent Docs) Myfortic7 (Mycophenolate) – US: Patent infringement suit filed in response to… [read post]
18 Nov 2009, 4:57 am
(Patent Docs) Dovonex (Calcipotriol) - UK: EWHC dismisses Sandoz appeal against Floyd J's finding that Leo Pharma's patent was valid (PatLit) Humira (Adalimumab): US: District Court E D Texas upholds record $1.7 billion infringement judgment: Centocor v Abbott (Patent Docs) (EDTexweblog.com) Lexapro (Citalopram) - US: Infosint seeks increased damages award in Citalopram suit (Patent Docs) Myfortic7 (Mycophenolate) - US: Patent infringement suit filed in response to Paragraph IV… [read post]
23 Feb 2011, 2:48 pm
Roche’s Boniva had 2010 revenue of $975 million, and Novartis’s Reclast and Aclasta had sales of $579 million.... [read post]
28 Sep 2011, 1:56 am
The AG’s opinion in Georgetown and Medeva (The SPC blog) Hungary: Repeatedly filed request for preliminary injunction – micronized active ingredient (EPLAW) Indonesia pharma patents and generic manufacture (IP Komodo) South Africa: Traditional Knowledge Bill debate – your views needed (Afro-IP) (Afro-IP) (Afro-IP) UK: Second round consultation on Patent Box proposal (including SPCs) ends (The SPC Blog) US: CAFC: Patent exhaustion does not apply to genetically engineered… [read post]
28 Jun 2016, 9:02 am
Novartis Pharm. [read post]
23 Mar 2011, 1:30 pm
The drug is jointly developed by Genentech Inc., a member of the Roche group, under an agreement with Novartis Pharma AG. [read post]
10 Feb 2010, 4:47 pm
– Crofelemer treatment for dehydration (Spicy IP) India: Nay patent linkages: Bayer v UOI upheld by Division Bench of Delhi High Court (Spicy IP) (Generic Pharmaceuticals and IP) India: Rejections from pre-grant appealable to IPAB by patent applicant: UCB Farchim SA v Cipla & Ors (Generic Pharmaceuticals and IP) (The Vanishing Point) (Indian Patent Oppositions) (Spicy IP) (Spicy IP) India: Buckuchurbu and (re) hydrating indian traditional knowledge (Spicy IP) Peru: Maize as cultural… [read post]
26 Oct 2007, 1:00 am
(Korea IP Law Blog), Korean trade mark law governs domain name disputes in Korea (Korea IP Law Blog), SpainLipitor patent upheld in Spain: (IPLaw 360), United Kingdom House of Lords overturns the Court of Appeal in the Yeda Appeal over Erbitux: (IPKat), (Inner Temple), (IP Law360), Novartis AG v IVAX Pharmaceuticals UK Ltd [2007] EWCA Civ 971, Court of Appeal dismisses an appeal against the decision of Mr Justice Pumfrey that Novartis' patent for a pharmaceutical… [read post]
13 Aug 2020, 12:38 pm
On June 25, 2020, the SEC announced settlement with drug company Novartis AG and its subsidiary Alcon Pte Ltd related to payments made by third parties in Asia and Europe to get doctors (including at state-owned hospitals) to prescribe Novartis drugs. [read post]
31 Mar 2015, 4:01 pm
They would mean that libraries can acquire and lend commercially available digital materials and, with archives, can continue to underpin knowledgeable societies in the digital age. [read post]
13 Dec 2021, 12:49 am
The meaning of Article 3(c) with respect to combination products was referred to the CJEU in Novartis (C-354/19) (IPKat). [read post]
21 Jul 2013, 5:38 pm
Lipimile, Director & Chief Executive Officer, COMESA Competition Commission • Ali Haddou Ruiz, Executive Secretary, The Federal Competition Commission, Mexico • Michele Piergiovanni, Case Manager, European Commission Merger Control Unit, European Commission • Carel Maske, Senior Attorney, Antitrust, Microsoft EMEA • Martin Commons, Senior Competition/Antitrust Counsel, BHP Billiton • Joerg Haering, Division General Counsel Legal & Compliance, Siemens • Susan… [read post]
22 Sep 2006, 12:17 pm
While the FDA has approved Novartis AG's Omnitrope hormone, there has not been a change in the stance taken by the FDA on generic biotechnology drugs. [read post]
15 Sep 2009, 2:30 pm
" The vaccines are made by CSL Limited, MedImmune LLC, Novartis Vaccines and Diagnostics Limited, and sanofi pasteur Inc. [read post]
9 Jun 2010, 8:28 am
This liability also extends to you if your supervisor or manager commits harassment based on race, color, sex, religion, national activity, age, protected activity, and disability. [read post]
24 May 2021, 7:34 am
The plaintiffs have accused Ranbaxy of delaying the launch of generic versions of Novartis AG’s high blood pressure drug Diovan, Pfizer Inc’s acid reflux drug Nexium and Genentech Inc’s antiviral drug Valcyte. [read post]
26 Nov 2007, 7:44 pm
Xenon announced in September 2004 that it had an agreement with Novartis Pharma AG to commercialize related compounds. [read post]
14 May 2009, 1:45 pm
The deals included Novartis AG's (NVS) acquisition of Eon Labs in 2005, Electronic Arts Inc. [read post]
22 Sep 2009, 1:30 pm
Xolair, which is made by Genentech and co-marketed by Novartis, was approved by the FDA in 2003. [read post]
